Normand Balthazard
Amministratore Delegato presso Prognomix, Inc.
Profilo
Normand Balthazard is the founder of CryoCath Technologies, Inc., ConjuChem, Inc., Biorthex, Inc., Intellivax International, Inc., and Origenix Technologies, Inc. Currently, he is the Co-Chief Executive Officer at Prognomix, Inc. In the past, he served as the President & Chief Executive Officer at BioCapital Investment Advisors, Inc. from 2002 to 2005.
He was also the Chairman, President, Secretary & Treasurer at Contact Image Corp.
from 2004 to 2007.
Additionally, he served as a Director at Savaria Corp.
from 2003 to 2010.
Posizioni attive di Normand Balthazard
| Società | Posizione | Inizio |
|---|---|---|
| Origenix Technologies, Inc. | Corporate Officer/Principal | - |
Intellivax International, Inc.
 Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Corporate Officer/Principal | - |
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Amministratore Delegato | - |
Precedenti posizioni note di Normand Balthazard
| Società | Posizione | Fine |
|---|---|---|
| SAVARIA CORPORATION | Direttore/Membro del Consiglio | 01/03/2010 |
Contact Image Corp.
 Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Presidente | 23/03/2007 |
BioCapital Investment Advisors, Inc.
 BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Presidente | 31/12/2005 |
Biorthex, Inc.
 Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Corporate Officer/Principal | - |
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAVARIA CORPORATION | Consumer Durables |
| Aziende private | 8 |
|---|---|
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Contact Image Corp.
Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Commercial Services |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
| Origenix Technologies, Inc. | |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Health Technology |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Health Technology |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Normand Balthazard
